Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade

Clinical trial NCT06874257 · RECRUITING

Trial details

NCT number: NCT06874257
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Status: RECRUITING
Study type: OBSERVATIONAL

AML (Acute Myelogenous Leukemia)

Start date: 2024-04-17
Primary completion: 2025-10-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.